ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.210,48
0,58%
S&P 500
5.187,70
0,13%
US Dollar vs BRL
5,0748
-0,03%
Bitcoin
62.510,99
-1,04%
Brent Oil
82,865
-0,73%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Homology Medicines Inc (FIXX)

  7. Homology Medicines Inc (FIXX) Notícias

FIXX

Homology Medicines (FIXX)

Homology Medicines Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FIXX
DataHoraFonteTítuloCódigoCompanhia
18/03/202417:30GlobeNewswire Inc.Homology Medicines Declares Distribution to Common StockholdersNASDAQ:FIXXHomology Medicines Inc
11/03/202408:37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
11/03/202408:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
15/02/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FIXXHomology Medicines Inc
13/02/202412:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FIXXHomology Medicines Inc
05/01/202419:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
03/01/202418:08GlobeNewswire Inc.Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyNASDAQ:FIXXHomology Medicines Inc
11/12/202318:15Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FIXXHomology Medicines Inc
17/11/202318:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
16/11/202309:05GlobeNewswire Inc.Q32 Bio and Homology Medicines Announce Merger AgreementNASDAQ:FIXXHomology Medicines Inc
14/11/202318:33GlobeNewswire Inc.Homology Medicines Reports Third Quarter 2023 Financial ResultsNASDAQ:FIXXHomology Medicines Inc
14/08/202317:05GlobeNewswire Inc.Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
14/08/202317:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FIXXHomology Medicines Inc
27/07/202317:05GlobeNewswire Inc.Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUNASDAQ:FIXXHomology Medicines Inc
27/07/202317:01GlobeNewswire Inc.Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKUNASDAQ:FIXXHomology Medicines Inc
15/06/202320:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FIXXHomology Medicines Inc
14/06/202317:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FIXXHomology Medicines Inc
16/05/202309:00GlobeNewswire Inc.Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
11/05/202317:05GlobeNewswire Inc.Homology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
11/05/202317:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FIXXHomology Medicines Inc
03/05/202308:30GlobeNewswire Inc.Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
28/04/202318:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FIXXHomology Medicines Inc
28/04/202317:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FIXXHomology Medicines Inc
28/04/202317:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FIXXHomology Medicines Inc
20/03/202307:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FIXXHomology Medicines Inc
16/03/202318:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FIXXHomology Medicines Inc
15/03/202317:01GlobeNewswire Inc.Homology Medicines Announces Presentations on Design of Ongoing Gene Editing and Gene Therapy Trials for PKU and Hunter Syndrome at ACMG Annual Clinical Genetics MeetingNASDAQ:FIXXHomology Medicines Inc
09/03/202318:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FIXXHomology Medicines Inc
09/03/202318:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FIXXHomology Medicines Inc
09/03/202318:05GlobeNewswire Inc.Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FIXX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
NGRD3
Neogrid Participacoes ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PRIO3
PETRORIO ON
BOV
IRBR3
IRB BRASIL ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV4
AZEVEDO PN
BOV
HAGA3
HAGA ON
BOV
OIBR3
OI ON
BOV
TPIS3
TRIUNFO PART ON
BOV
TELB4
TELEBRAS PN
BOV
VVEO3
CM Hospitalar ON
BOV
BRKM5
BRASKEM PNA
BOV
ETER3
ETERNIT ON
BOV
KRSA3
Kora Saude Participacoes... ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados